MDGL Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).

$77.11  -0.92 (-1.18%)
As of 12/06/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2007
Outstanding shares:  17,097,090
Average volume:  105,864
Market cap:   $1,334,085,933
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    558868105
ISIN:        US5588681057
Sedol:      BD59BS7
Valuation   (See tab for details)
PE ratio:   -7.52
PB ratio:   5.60
PS ratio:   0.00
Return on equity:   -100.66%
Net income %:   -81,133.30%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy